Rigel Pharmaceuticals Prepares for Impact at ASH Annual Meeting
Rigel Pharmaceuticals Set to Shine at ASH Annual Meeting Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a dedicated biotechnology company focused on hematologic disorders and cancer, is gearing up to present six insightful posters at the upcoming American Society of Hematology (ASH) Annual Meeting and Exposition. This prestigious event is scheduled to take place from...
Continue Reading